Cost evaluation of basiliximab treatment for renal transplant patients in Japan.
Hasegawa
T
T
Department of Public Health, Toho University School of Medicine, Tokyo, Japan. tommie@med.toho-u.ac.jp
Imai
H
H
Miki
S
S
D000911:Antibodies, Monoclonal / Q000191:economics* / Q000627:therapeutic use; D000077552:Basiliximab; D003362:Cost-Benefit Analysis; D003365:Costs and Cost Analysis; D006801:Humans; D007166:Immunosuppressive Agents / Q000191:economics / Q000627:therapeutic use; D007564:Japan; D016030:Kidney Transplantation / Q000191:economics / Q000276:immunology*; D011993:Recombinant Fusion Proteins
D000911:Antibodies, Monoclonal; D007166:Immunosuppressive Agents; D011993:Recombinant Fusion Proteins; D000077552:Basiliximab